Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Hurabielle C et al. | Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease. | 2016 | J Dermatolog Treat | pmid:25909366 |
Muduma G et al. | Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant. | 2016 | PLoS ONE | pmid:27812112 |
Prókai à et al. | Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. | 2016 | Transplantation | pmid:26502369 |
Unver Dogan N et al. | Investigation of developmental toxicity and teratogenicity of cyclosporine A, tacrolimus and their combinations with prednisolone. | 2016 | Regul. Toxicol. Pharmacol. | pmid:26993750 |
Garcovich S et al. | First report of hereditary Christ-Siemens-Touraine syndrome and non-segmental vitiligo association in a young adult: contraindication for vitiligo treatment. | 2016 | J Eur Acad Dermatol Venereol | pmid:25339629 |
Ferjani H et al. | Combination of tacrolimus and mycophenolate mofetil induces oxidative stress and genotoxicity in spleen and bone marrow of Wistar rats. | 2016 | Mutat. Res. | pmid:27776691 |
Deng S et al. | Mechanism of tacrolimus-induced chronic renal fibrosis following transplantation is regulated by ox-LDL and its receptor, LOX-1. | 2016 | Mol Med Rep | pmid:27633115 |
Fathy M et al. | Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience. | 2016 | Biomarkers | pmid:26856709 |
Størset E et al. | Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience. | 2016 | Nephrology (Carlton) | pmid:26854648 |
Novosel MK and Bistrup C | Discontinuation of steroids in ABO-incompatible renal transplantation. | 2016 | Transpl. Int. | pmid:26706618 |
Suh SW et al. | Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients. | 2016 | J. Korean Med. Sci. | pmid:27709847 |
Yamamoto T et al. | Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study. | 2016 | Aliment. Pharmacol. Ther. | pmid:26762838 |
Witt LJ et al. | Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. | 2016 | Pulm Pharmacol Ther | pmid:26762710 |
Dayal S et al. | Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy. | 2016 | Pediatr Dermatol | pmid:27699846 |
Bakardzhiev I et al. | Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem. | 2016 | Wien Med Wochenschr | pmid:26762262 |
Singh JA et al. | Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis. | 2016 | J. Rheumatol. | pmid:27585688 |
Jones-Hughes T et al. | Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. | 2016 | Health Technol Assess | pmid:27578428 |
Saito S et al. | Role of Paternal Antigen-Specific Treg Cells in Successful Implantation. | 2016 | Am. J. Reprod. Immunol. | pmid:26706630 |
Georgiou GK et al. | Calcineurin inhibitors and male fertility after renal transplantation - a review. | 2016 | Andrologia | pmid:26341518 |
Herden U et al. | Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience. | 2016 | Ann. Transplant. | pmid:26842532 |
Thomas KS et al. | Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study. | 2016 | J. Am. Acad. Dermatol. | pmid:27502313 |
Yamaguchi Y et al. | Plasma cell cheilitis successfully treated with topical calcineurin inhibitors. | 2016 | Eur J Dermatol | pmid:27502182 |
Shuker N et al. | Pretransplant Tacrolimus Dose Requirements Predict Early Posttransplant Dose Requirements in Blood Group AB0-Incompatible Kidney Transplant Recipients. | 2016 | Ther Drug Monit | pmid:26630539 |
Turrión-Merino L et al. | A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response. | 2016 | Actas Dermosifiliogr | pmid:26626501 |
Uemoto S et al. | Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients. | 2016 | Clin. Exp. Immunol. | pmid:26560892 |
Niioka T et al. | Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients. | 2016 | Int. J. Urol. | pmid:26990259 |
Ogura Y et al. | Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience. | 2016 | Ann. Transplant. | pmid:27432248 |
Shijo T et al. | A mismatch between MRI lesions and SPECT hypoperfusion in tacrolimus-related encephalopathy. | 2016 | J. Neurol. Sci. | pmid:27423609 |
Asavakarn S et al. | Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients. | 2016 | Transplant. Proc. | pmid:27320587 |
Limsrichamrern S et al. | Correlation of Hematocrit and Tacrolimus Level in Liver Transplant Recipients. | 2016 | Transplant. Proc. | pmid:27320581 |
Kim JD et al. | Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. | 2016 | Transplant. Proc. | pmid:27320573 |
Federico S et al. | Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration. | 2016 | Eur. J. Clin. Invest. | pmid:27240092 |
Mo S et al. | Improvement of FK506 Production in the High-Yielding Strain Streptomyces sp. RM7011 by Engineering the Supply of Allylmalonyl-CoA Through a Combination of Genetic and Chemical Approach. | 2016 | J. Microbiol. Biotechnol. | pmid:26502733 |
Sharma P et al. | Protein Phosphatase 1-α Regulates AS160 Ser588 and Thr642 Dephosphorylation in Skeletal Muscle. | 2016 | Diabetes | pmid:27246912 |
Prytuła A et al. | Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study. | 2016 | Endocrine | pmid:26433738 |
Lazelle RA et al. | Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension. | 2016 | J. Am. Soc. Nephrol. | pmid:26432904 |
Nitta D et al. | Successful Pregnancy and Delivery in a Heart Transplantation Recipient. | 2016 | Int Heart J | pmid:27150004 |
Jovanović M and Golušin Z | Nonsteroidal Topical Immunomodulators in Allergology and Dermatology. | 2016 | Biomed Res Int | pmid:27144167 |
Ban YH et al. | The biosynthetic pathway of FK506 and its engineering: from past achievements to future prospects. | 2016 | J. Ind. Microbiol. Biotechnol. | pmid:26342319 |
Romano C et al. | Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era. | 2016 | Pediatrics | pmid:27244779 |
Fujii S et al. | Prior activation of inositol 1,4,5-trisphosphate receptors suppresses the subsequent induction of long-term potentiation in hippocampal CA1 neurons. | 2016 | Learn. Mem. | pmid:27084928 |
Han SS et al. | Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function. | 2016 | PLoS ONE | pmid:27082871 |
Bianic F et al. | Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting. | 2016 | J Med Econ | pmid:27081739 |
Mok CC et al. | Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. | 2016 | Ann. Rheum. Dis. | pmid:25550339 |
Ikeda M et al. | Successful Second Allogeneic Stem Cell Transplantation From a Sibling Donor for Relapse of Myelodysplastic Syndrome in a Recipient of a Renal Transplant From His Mother: Case Report. | 2016 | Transplant. Proc. | pmid:27932152 |
Suarez Benjumea A et al. | Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. | 2016 | Transplant. Proc. | pmid:27932111 |
Rodriguez Cubillo B et al. | Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. | 2016 | Transplant. Proc. | pmid:27932117 |
Pallet N et al. | Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. | 2016 | Am. J. Transplant. | pmid:26990694 |
Awdishu L and Joy MS | Role of Pharmacogenomics in Kidney Disease and Injury. | 2016 | Adv Chronic Kidney Dis | pmid:26979149 |
Stockwell J et al. | Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia/reperfusion injury. | 2016 | Neuropharmacology | pmid:26626486 |